Plasma homocysteine levels in HIV-infected men with and without lipodystrophy

Rafael Deminice1, Helena S Vassimon, Alcyone A Machado

  • 1Laboratory of Nutrition and Metabolism, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil; Department of Physical Education, Institute of Physical Education and Sport, State University of Londrina, Campus Universitário, Londrina, Paraná, Brazil.

Insights

HIV patients with lipodystrophy show higher homocysteine levels, linked to cardiovascular disease risk. Factors like HAART duration, insulin, and adiponectin influence these metabolic disturbances.

Area of Science:

  • Endocrinology
  • Cardiovascular Disease
  • Infectious Disease

Background:

  • Lipodystrophy syndrome in HIV patients is linked to increased cardiovascular disease (CVD) risk.
  • Hyperhomocysteinemia is a known risk factor for CVD.

Purpose of the Study:

  • To investigate homocysteine (Hcy) levels in men with HIV.
  • To examine the association between Hcy levels and lipodystrophy syndrome factors in HIV-infected men.

Main Methods:

  • Measured Hcy metabolism-related molecules in three groups: HIV+lipodystrophy (HIV+LIP), HIV without lipodystrophy (HIV), and healthy controls (C).

Main Results:

  • Elevated plasma Hcy levels were observed in both HIV and HIV+LIP groups compared to controls.
  • HIV patients had lower plasma vitamin B12 and folate levels.
  • HIV+LIP men showed increased plasma total sulfur-containing amino acids and lower total plasma thiol compared to controls.
  • Plasma Hcy correlated significantly with HAART duration, plasma insulin, and adiponectin levels.

Conclusions:

  • HIV+LIP men exhibit greater susceptibility to Hcy metabolism disturbances than HIV men without lipodystrophy.
  • HAART duration, elevated plasma insulin, and low adiponectin are implicated in Hcy metabolic disorders in this population.
Abstract